Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
Open accessThe DOI matches its Crossref record; 122 of the 125 references it cites were found in a registry or an index.
Abstract
Cancer tissues are composed of cancer cells and the surrounding stromal cells (e.g., fibroblasts, vascular endothelial cells, and immune cells), in addition to the extracellular matrix. Most studies investigating carcinogenesis and the progression, invasion, metastasis, and angiogenesis of cancer have focused on alterations in cancer cells, including genetic and epigenetic changes. Recently, interactions between cancer cells and the stroma have attracted considerable attention, and increasing evidence has accumulated on this. Several researchers have gradually clarified the origins, features, and roles of cancer-associated fibroblasts (CAFs), a major component of the cancer stroma. CAFs function in a similar manner to myofibroblasts during wound healing. We previously reported the relationship between CAFs and angiogenesis. Interleukin-6 (IL-6), a multifunctional cytokine, plays a central role in regulating inflammatory and immune responses, and important roles in the progression, including proliferation, migration, and angiogenesis, of several cancers. We showed that CAFs are an important IL-6 source and that anti-IL-6 receptor antibody suppressed angiogenesis and inhibited tumor-stroma interactions. Furthermore, CAFs contribute to drug-resistance acquisition in cancer cells. The interaction between cancer cells and the stroma could be a potential target for anti-cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, recent studies indicated that CAFs consist of several types of stromal cells that differ in their origin, functions, number, and phenotype [21, 22, 23, 24].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer
Sun, X., Mao, Y., Wang, J., Zu, L., Hao, M., Cheng, G., Qu, Q., Cui, D., Keller, E. T., Chen, X., et al. (2014) · Oncogene · doi:10.1038/onc.2014.158 · Cited by 75
RetractedSun, X., Mao, Y., Wang, J., Zu, L., Hao, M., Cheng, G., Qu, Q., Cui, D., Keller, E. T., CHEN, X., et al. (2014) · Oncogene · doi:10.1038/onc.2014.224 · Cited by 40
RetractedChen, L., Qu, C., Chen, H., Xu, L., Qi, Q., Luo, J., Wang, K., Meng, Z., Chen, Z., Wang, P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096177 · Cited by 30
RetractedWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 1×
“This phenomenon is known as “Warburg effect” [84].”
BackgroundThe distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“proposed the theory that a “tumor is a wound that never heals” [2].”
BackgroundThe Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290 · cited 2×
“These myofibroblasts acquire de novo expressed α-SMA, contractile stress fibers, and the ED-A splice variant of fibronectin [5,7].”
BackgroundComplex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Cited by
Items 201–300 of 814
Sha, M., Jeong, S., Qiu, B., Tong, Y., Xia, L., Xu, N., Zhang, J., & Xia, Q. (2018) · Cancer Medicine · doi:10.1002/cam4.1704 · Cited by 65
Ramirez, M. U., Hernandez, S. R., Soto‐Pantoja, D. R., & Cook, K. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010169 · Cited by 63
How Signaling Molecules Regulate Tumor Microenvironment: Parallels to Wound Repair
Gál, P., Varinská, L., Fáber, L., Novak, S., Szabó, P., Mitrengová, P., Miroššay, A., Mučaji, P., & Smetana, K. (2017) · Molecules · doi:10.3390/molecules22111818 · Cited by 62
3D cell coculture tumor model: A promising approach for future cancer drug discovery
Xin, X., Yang, H. K., Zhang, F., & Yang, S. (2018) · Process Biochemistry · doi:10.1016/j.procbio.2018.12.028 · Cited by 64
Multifunctional Biomedical Materials Derived from Biological Membranes
Wang, Y., Xu, X., Chen, X., & Li, J. (2022) · Advanced Materials · doi:10.1002/adma.202107406 · Cited by 63
A Review of Exosomes and their Role in The Tumor Microenvironment and Host-Tumor "Macroenvironment"
Tung, K. H.-Y., Ernstoff, M. S., Allen, C. L., & Shu, S. L. (2019) · Journal of Immunological Sciences · doi:10.29245/2578-3009/2019/1.1165 · Cited by 61
Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer
Salimifard, S., Masjedi, A., Hojjat‐Farsangi, M., Ghalamfarsa, G., Irandoust, M., Azizi, G., Mohammadi, H., Keramati, M. R., & Jadidi‐Niaragh, F. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.152915 · Cited by 60
The role of tumor microenvironment and exosomes in dormancy and relapse
Attaran, S., & Bissell, M. J. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.09.008 · Cited by 61
Ng, J. C.-F., Quist, J., Grigoriadis, A. E., Malim, M. H., & Fraternali, F. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1316 · Cited by 61
Cancer-Associated Fibroblasts in the Breast Tumor Microenvironment
Giorello, M. B., Borzone, F. R., Labovsky, V., Piccioni, F., & Chasseing, N. A. (2021) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-020-09475-y · Cited by 60
Cancer-Associated Fibroblast Functions as a Road-Block in Cancer Therapy
De, P. K., Aske, J. C., & Dey, N. (2021) · Cancers · doi:10.3390/cancers13205246 · Cited by 59
Optimizing Advances in Nanoparticle Delivery for Cancer Immunotherapy
Caster, J. M., Callaghan, C. M., Seyedin, S. N., Henderson, K., Sun, B., & Wang, A. Z. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.07.009 · Cited by 56
Kim, K., Jung, J., Yoo, H. J., Hyun, J., Park, J., Na, D., & Yeon, J. H. (2020) · Journal of Functional Biomaterials · doi:10.3390/jfb11030049 · Cited by 55
Watanabe, K., Shiga, K., Maeda, A., Harata, S., Yanagita, T., Suzuki, T., Ushigome, H., Maeda, Y., Hirokawa, T., Ogawa, R., et al. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5293 · Cited by 56
Self-citationStromal contributions to the carcinogenic process
Spaw, M., Anant, S., & Thomas, S. M. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22583 · Cited by 51
Thy-1/CD90 a Bidirectional and Lateral Signaling Scaffold
Leyton, L., Díaz, J., Martínez, S., Palacios, E., González, L. P., & Pérez, R. D. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00132 · Cited by 55
The tumour microenvironment of pituitary neuroendocrine tumours
Marques, P., Grossman, A. B., & Korbonits, M. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100852 · Cited by 57
Yan, H., Guo, B.-Y., & Zhang, S. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.131 · Cited by 55
Koh, B., Jeon, H., Kim, D., Kang, D., & Kim, K. S. (2018) · Oncology Letters · doi:10.3892/ol.2018.9836 · Cited by 56
Baj, J., Brzozowska, K., Forma, A., Maani, A., Sitarz, R., & Portincasa, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072544 · Cited by 57
ERK and c-Myc signaling in host-derived tumor endothelial cells is essential for solid tumor growth
Zuo, Z., Liu, J., Sun, Z., Cheng, Y., Ewing, M., Bugge, T. H., Finkel, T., Leppla, S. H., & Liu, S. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211927120 · Cited by 58
Giusti, I., Francesco, M. D., Poppa, G., Esposito, L., D’Ascenzo, S., & Dolo, V. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.839880 · Cited by 54
Bhome, R., Emaduddin, M., James, V. H., House, L. M., Thirdborough, S. M., Mellone, M., Tulkens, J., Primrose, J. N., Thomas, G. J., Wever, O. D., et al. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12226 · Cited by 53
Nanoparticles designed to regulate tumor microenvironment for cancer therapy
Li, M., Zhang, F., Su, Y., Zhou, J., & Wang, W. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.03.044 · Cited by 54
Stromal Cells Present in the Melanoma Niche Affect Tumor Invasiveness and Its Resistance to Therapy
Mazurkiewicz, J., Simiczyjew, A., Dratkiewicz, E., Ziętek, M., Matkowski, R., & Nowak, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020529 · Cited by 56
SRC Signaling in Cancer and Tumor Microenvironment
Caner, A., Aşık, E., & Özpolat, B. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-47189-7_4 · Cited by 52
Rakina, M. A., Казакова, А., Виллерт, А. Б., Коломиец, Л. А., & Larionova, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116215 · Cited by 55
Anari, F., Ramamurthy, C., & Zibelman, M. (2018) · Future Oncology · doi:10.2217/fon-2017-0585 · Cited by 50
Defining Skin Fibroblastic Cell Types Beyond CD90
Jiang, D., & Rinkevich, Y. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00133 · Cited by 51
Kim, H. J., Yang, K., Kim, K., Lee, Y., Lee, S., Ahn, S. Y., Ahn, Y., & Kang, J. L. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-022-00930-w · Cited by 50
“The most widely used marker for CAFs is α-SMA because this protein is a specific marker for myofibroblasts [31].”
BackgroundWang, W., Li, T., Xie, Z., Zhao, J., Zhang, Y., Ruan, Y., & Han, B. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-023-04807-y · Cited by 52
Yoriki, K., Mori, T., Kokabu, T., Matsushima, H., Umemura, S., Tarumi, Y., & Kitawaki, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-43261-z · Cited by 57
Sapudom, J., Müller, C. D., Nguyen, K.-T., Martin, S., Anderegg, U., & Pompe, W. (2020) · Gels · doi:10.3390/gels6040033 · Cited by 50
Cancer-Associated Fibroblasts: Epigenetic Regulation and Therapeutic Intervention in Breast Cancer
Lee, Y. T., Tan, Y. J., Falasca, M., & Oon, C. E. (2020) · Cancers · doi:10.3390/cancers12102949 · Cited by 51
Nii, T., Makino, K., & Tabata, Y. (2019) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2019.0189 · Cited by 49
Song, H., Zhao, Z., Ma, L., Zhao, W., Hu, Y., & Song, Y. (2024) · Oncogene · doi:10.1038/s41388-024-02950-4 · Cited by 49
Offeddu, G. S., Cambria, E., Shelton, S. E., Haase, K., Wan, Z., Possenti, L., Nguyen, H. T., Gillrie, M. R., Hickman, D., Knutson, C. G., et al. (2024) · Advanced Science · doi:10.1002/advs.202402757 · Cited by 53
Mauro, N., Scialabba, C., Pitarresi, G., & Giammona, G. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.045 · Cited by 49
Yoshino, F., Amano, T., Zou, Y., Xu, J., Kimura, F., Furusho, Y., Chano, T., Murakami, T., Zhao, L., & Komatsu, N. (2019) · Small · doi:10.1002/smll.201901930 · Cited by 49
Yamamoto, S., Kato, A., Sakurai, Y., Hada, T., & Harashima, H. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.010 · Cited by 46
Mesenchymal Stem Cell Marker Expression in Gastric Cancer Stroma
Numakura, S., Uozaki, H., Kikuchi, Y., Watabe, S., 有紗, 富., & Watanabe, M. (2018) · Anticancer Research · doi:10.21873/anticanres.13124 · Cited by 47
Inflammatory fibroblasts in cancer
Lim, H., & Moon, A. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0787-8 · Cited by 48
Ma, S., McGuire, M. H., Mangala, L. S., Lee, S., Stur, E., Hu, W. S., Bayraktar, E., Villar‐Prados, A., Ivan, C., Wu, S. Y., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108726 · Cited by 47
Hsiao, Y., Chi, J.-Y., Li, C., Chen, L., Chen, Y., Liang, H., Lo, Y.-C., Hong, J., Chuu, C., Hung, L., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.724 · Cited by 52
Mesenchymal Stromal Cells: Emerging Roles in Bone Metastasis
Graham, N., & Qian, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041121 · Cited by 47
Fridman, I. B., Kostas, J. C., Greguš, M., Ray, S., Sullivan, M. R., Ivanov, A. R., Cohen, S., & Konry, T. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.06.025 · Cited by 46
Autophagy: A promising target for triple negative breast cancers
El-Aziz, Y. S. A., Gillson, J., Jansson, P. J., & Sahni, S. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106006 · Cited by 47
Dana, P., Thumrongsiri, N., Tanyapanyachon, P., Chonniyom, W., Punnakitikashem, P., & Saengkrit, N. (2022) · Nanomaterials · doi:10.3390/nano13010107 · Cited by 53
Entezam, M., Sanaei, M., Mirzaei, Y., Mer, A. H., Abdollahpour‐Alitappeh, M., Azadegan‐Dehkordi, F., & Bagheri, N. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121459 · Cited by 47
Limoge, M., Safina, A. F., Truskinovsky, A. M., Aljahdali, I. A. M., Zonneville, J., Gruevski, A., Arteaga, C. L., & Bakin, A. V. (2017) · Oncotarget · doi:10.18632/oncotarget.18755 · Cited by 46
Cao, H., Lee, M. K. H., Yang, H., Sze, S. K., Tan, N. S., & Tay, C. Y. (2018) · Langmuir · doi:10.1021/acs.langmuir.8b02649 · Cited by 46
Zou, T., Lü, W., Mezhuev, Y. O., Lan, M., Li, L., Liu, F., Cai, T., Wu, X. Y., & Cai, Y. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.05.029 · Cited by 47
Strategies Using Gelatin Microparticles for Regenerative Therapy and Drug Screening Applications
Nii, T. (2021) · Molecules · doi:10.3390/molecules26226795 · Cited by 47
Hara, M., Nagasaki, T., Shiga, K., Takahashi, H., & Takeyama, H. (2016) · Surgery Today · doi:10.1007/s00595-016-1404-7 · Cited by 45
Self-citationNano drug delivery system reconstruct tumour vasculature for the tumour vascular normalisation
Liang, Q., Zhou, L., Li, Y., Liu, J., & Liu, Y. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.1927056 · Cited by 46
Ren, X., Li, L., Wu, J., Lin, K. Y., He, Y., & Bian, L. (2021) · Oncology Letters · doi:10.3892/ol.2021.12798 · Cited by 47
Limoge, M., Safina, A. F., Beattie, A., Kapus, L., Truskinovsky, A. M., & Bakin, A. V. (2017) · Oncotarget · doi:10.18632/oncotarget.16022 · Cited by 45
Zhang, R., Qi, F., Shao, S., Li, G., & Feng, Y. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0914-y · Cited by 39
Cho, J., Byeon, H. K., Oh, K. H., Baek, S., Kwon, S. Y., Jung, K., & Woo, J. (2018) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-018-5061-x · Cited by 42
Geng, F., Bao, X., Dong, L., Guo, Q., Guo, J., Xie, Y., Zhou, Y., Yu, B., Wu, H., Wu, J., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1747350 · Cited by 45
Mapping the Metabolic Networks of Tumor Cells and Cancer-Associated Fibroblasts
Karta, J., Bossicard, Y., Kotzamanis, K., Dolznig, H., & Letellier, E. (2021) · Cells · doi:10.3390/cells10020304 · Cited by 44
Mostafavi, S., Zalpoor, H., & Hassan, Z. M. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00356-2 · Cited by 43
Deciphering the complexities of cancer cell immune evasion: Mechanisms and therapeutic implications
Gupta, I., Hussein, O., Sastry, K. S., Bougarn, S., Gopinath, N., Chin-Smith, E. C., Sinha, Y., Korashy, H. M., & Maccalli, C. (2023) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2023.100107 · Cited by 44
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Lv, K., & He, T. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00233-8 · Cited by 42
Yang, W., Cai, S., Yuan, Z., Lai, Y., Yu, H., Wang, Y., & Liu, L. (2019) · Materials & Design · doi:10.1016/j.matdes.2019.108182 · Cited by 42
Grote, S., Ureña-Bailén, G., Chan, K. C.-H., Baden, C., Mezger, M., Handgretinger, R., & Schleicher, S. (2021) · Cells · doi:10.3390/cells10051020 · Cited by 41
Wang, Y., Takeishi, K., Li, Z., Cervantes‐Alvarez, E., de l’Hortet, A. C., Guzman‐Lepe, J., Cui, X., & Zhu, J. (2017) · Organogenesis · doi:10.1080/15476278.2017.1322243 · Cited by 40
Mathot, P., Grandin, M., Devailly, G., Souazé, F., Cahais, V., Morán, S., Campone, M., Herceg, Z., Esteller, M., Juin, P. P., et al. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.88 · Cited by 40
The role of the tumour microenvironment in the angiogenesis of pituitary tumours
Marques, P., Barry, S., Carlsen, E., Collier, D., Ronaldson, A., Dorward, N., Grieve, J., Mendoza, N., Nair, R., Muquit, S., et al. (2020) · Endocrine · doi:10.1007/s12020-020-02478-z · Cited by 41
Chemotherapy resistance and stromal targets in breast cancer treatment: a review
van der Spek, Y. M., Kroep, J. R., Tollenaar, R. A. �. �., & Mesker, W. E. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05853-1 · Cited by 42
Tumor‐stroma interactions differentially alter drug sensitivity based on the origin of stromal cells
Landry, B. D., Leete, T., Richards, R., Cruz‐Gordillo, P., Schwartz, H. R., Honeywell, M. E., Ren, G., Schwartz, A. D., Peyton, S. R., & Lee, M. J. (2018) · Molecular Systems Biology · doi:10.15252/msb.20188322 · Cited by 39
Zhang, Y., Ho, S., Li, B., Nie, G., & Li, S. (2019) · Medicinal Research Reviews · doi:10.1002/med.21644 · Cited by 40
Gordillo, C. H., Sandoval, P., Muñoz-Hernández, P., Pascual-Antón, L., López-Cabrera, M., & Jiménez-Heffernan, J. A. (2020) · Cancers · doi:10.3390/cancers12020499 · Cited by 40
Emerging functions and clinical applications of exosomes in human oral diseases
Peng, Q., Yang, J., & Zhou, G. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00424-0 · Cited by 44
Chen, J., Wang, Y., Zhang, W., Zhao, D., Zhang, L., Zhang, J., Fan, J., & Zhan, Q. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.472 · Cited by 40
Role of Peritoneal Mesothelial Cells in the Progression of Peritoneal Metastases
Li, J., & Guo, T. (2022) · Cancers · doi:10.3390/cancers14122856 · Cited by 39
Regulations of Tumor Microenvironment by Prostaglandins
Nie, J. Z., Wang, M.-T., & Nie, D. (2023) · Cancers · doi:10.3390/cancers15123090 · Cited by 40
Moncada, R., Wagner, F., Chiodin, M., Devlin, J. C., Baron, M., Hajdu, C. H., Simeone, D. M., & Yanai, I. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/254375 · Cited by 41
Казакова, А., Sudarskikh, T., Kovalev, O. I., Kzhyshkowska, J. G., & Larionova, I. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5480 · Cited by 38
Andriani, F., Majorini, M. T., Mano, M., Landoni, E., Miceli, R., Facchinetti, F., Mensah, M., Fontanella, E., Dugo, M., Giacca, M., et al. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0594-4 · Cited by 39
Ba, P., Xu, M., Yu, M., Li, L., Duan, X., Lv, S., Fu, G., Yang, J., Yang, P., Yang, C., et al. (2020) · Oral Diseases · doi:10.1111/odi.13306 · Cited by 38
Nii, T., Kuwahara, T., Makino, K., & Tabata, Y. (2020) · Tissue Engineering Part A · doi:10.1089/ten.tea.2020.0095 · Cited by 39
FAPI PET/CT in the Diagnosis of Abdominal and Pelvic Tumors
Yang, T., Ma, L., Hou, H., Gao, F., & Tao, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.797960 · Cited by 42
Epigenetic Regulation of Myofibroblast Phenotypes in Fibrosis
Duong, T. E., & Hagood, J. S. (2018) · Current Pathobiology Reports · doi:10.1007/s40139-018-0155-0 · Cited by 40
Multiscale Modelling of Fibres Dynamics and Cell Adhesion within Moving Boundary Cancer Invasion
Shuttleworth, R., & Trucu, D. (2019) · Bulletin of Mathematical Biology · doi:10.1007/s11538-019-00598-w · Cited by 41
Ando, N., Hara, M., Shiga, K., Yanagita, T., Takasu, K., Nakai, N., Maeda, Y., Hirokawa, T., Takahashi, H., Ishiguro, H., et al. (2019) · Oncology Reports · doi:10.3892/or.2019.7141 · Cited by 37
Self-citationCutaneous Metastasis after Surgery, Injury, Lymphadenopathy, and Peritonitis: Possible Mechanisms
Otsuka, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133286 · Cited by 38
Pan, C., Liu, P., Ma, D., Zhang, S., Ni, M., Fang, Q., & Wang, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110610 · Cited by 37
Emerging insights into the biology of metastasis: A review article.
Irani, S. (2019) · PubMed Central · doi:10.22038/ijbms.2019.32786.7839 · Cited by 42
Jain, S. M., Ravichandran, S. N., Kumar, M. M., Banerjee, A., Sun-Zhang, A., Zhang, H., Pathak, R., Sun, X., & Pathak, S. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2317999 · Cited by 37
Kemi, N., Eskuri, M., & Kauppila, J. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-52606-7 · Cited by 37
Identifying progression predictors of breast ductal carcinoma in situ
Yeong, J. P.-S., Thike, A. A., Tan, P. H., & Iqbal, J. (2016) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2016-204154 · Cited by 40
Chen, G., Yu, C., Tang, Z., Liu, S., An, F., Zhu, J., Wu, Q., Cao, J., Zhan, Q., & Zhang, S. (2018) · Oncology Reports · doi:10.3892/or.2018.6783 · Cited by 37
Siljamäki, E., Rappu, P., Riihilä, P., Nissinen, L. M., Kähäri, V., & Heino, J. (2019) · Matrix Biology · doi:10.1016/j.matbio.2019.09.001 · Cited by 36
Chen, H., Fang, S.-P., Zhu, X., & Liu, H. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1412337 · Cited by 35
Kewitz, S., Windisch, N., Hause, G., Müller, L. P., Sunderkötter, C. H., & Gerloff, D. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12509 · Cited by 37
YAP and WWTR1: New targets for skin cancer treatment
Andl, T., Zhou, L., YANG, K. Y., Kadekaro, A. L., & Zhang, Y. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.001 · Cited by 35
Immune Cell Metabolism in Tumor Microenvironment
Li, Y., Wan, Y. Y., & Zhu, B. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-1170-6_5 · Cited by 37
Wawro, M. E., Chojnacka, K., Wieczorek-Szukała, K., Sobierajska, K., & Niewiarowska, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010053 · Cited by 32
Tu, Y., Johnstone, C. N., & Stewart, A. G. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.02.011 · Cited by 39
Metadata
- Authors
- Shiga, K., Hara, M., Nagasaki, T., Sato, T., Takahashi, H., & Takeyama, H.
- Affiliations
- Nagoya City University (JP)
- Corresponding author
- Hara, Masayasu
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2015-12-11
- Volume
- 7
- Issue
- 4
- Pages
- 2443-2458
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC4695902
- OpenAlex
- W2190528488
- Cited by
- 774
- References
- 125
- Citations by year
- 2026: 29 · 2025: 42 · 2024: 61 · 2023: 71 · 2022: 83 · 2021: 103 · 2020: 121 · 2019: 104 · 2018: 87 · 2017: 49 · 2016: 21
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- cancer-associated fibroblasts, tumor microenvironment, tumor stroma, tumor-stroma interactions, angiogenesis, interleukin-6, IL-6 receptor, myofibroblasts, drug resistance, tumor progression, cancer therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.